Moderna asks FDA to authorize second booster for all adults
Moderna yesterday asked the Food and Drug Administration to authorize a second booster dose of its COVID-19 vaccine for adults age 18 and older who received an initial booster of any authorized or approved COVID-19 vaccine, citing published data from the United States and Israel after the omicron variant emerged. The company said the request includes all adults to give the Centers for Disease Control and Prevention and health care providers flexibility to determine the appropriate use for an additional booster, including for those at higher risk due to age or health conditions.
Related News Articles
Headline
The Department of Health of Human Services Aug. 21 issued a request for information seeking feedback on immunization categories within the Aug. 10 executive…
Headline
For the 2025-2026 school year, exemptions from one or more vaccines among U.S. kindergartners was at 4.2%, increasing from 3.6% for the previous school year,…
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…